Clinical Trials Logo

Clinical Trial Summary

Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.


Clinical Trial Description

Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02434653
Study type Interventional
Source HaEmek Medical Center, Israel
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date May 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05590260 - Prevention of Iron Deficiency Anemia Post-delivery Phase 3
Completed NCT01628770 - Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia N/A
Completed NCT00354484 - Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients Phase 3
Recruiting NCT02656225 - Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome Phase 1/Phase 2
Not yet recruiting NCT06175117 - Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ) Phase 4
Completed NCT02458625 - A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia N/A